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The Notch signaling pathway regulates intestinal epithelial cell homeostasis, including stem cell main-
tenance, progenitor cell proliferation and differentiation. Notch1 and Notch2 receptors are expressed in
the epithelium, but individual contributions to these functions are unclear. We used genetic deletion to
deﬁne receptor roles on stem cell function, cell proliferation/differentiation, and repair after injury. Loss
of Notch1 induced a transient secretory cell hyperplasia that spontaneously resolved over time. In con-
trast, deletion of Notch2 had no secretory cell effect. Compound deletions of Notch1 and Notch2 resulted
in a more severe secretory cell hyperplasia than deletion of Notch1 alone. Furthermore, only double
deletion of Notch1 and Notch2 decreased cell proliferation, suggesting a low threshold for maintenance of
proliferation compared to differentiation. Stem cells were affected by deletion of Notch1, with reduced
expression of Olfm4 and fewer LGR5þ stem cells. Deletion of Notch2 had no apparent affect on stem cell
homeostasis. However, we observed impaired crypt regeneration after radiation in both Notch1- and
Notch2-deleted intestine, suggesting that higher Notch activity is required post-injury. These ﬁndings
suggest that Notch1 is the primary receptor regulating intestinal stem cell function and that Notch1 and
Notch2 together regulate epithelial cell proliferation, cell fate determination, and post-injury regenera-
tion.
& 2015 Elsevier Inc. All rights reserved.Introduction
The continuous renewal of the intestinal epithelium is fueled by
active stem cells located at the crypt base. Although intestinal stem
cells have been a topic of investigation for several decades, the
discovery of LGR5 as a speciﬁc marker of the active stem cell
population sparked a recent expansion of this ﬁeld of study (Barker
et al., 2007). LGR5þ intestinal stem cells divide to produce daughters
that can become stem or transit-amplifying (TA) cells depending on
competition for open stem cell niche spots (Snippert et al., 2010).
The TA cells are short-lived, highly proliferative progenitors that
expand epithelial cell numbers and differentiate into the various
epithelial cell types, including absorptive enterocytes, mucous-
secreting goblet cells, antimicrobial peptide-secreting Paneth cells
and hormone-secreting enteroendocrine cells. The molecularlar & Integrative Physiology,
Ann Arbor, MI 48109, USA.
).mechanisms that regulate intestinal stem cell number and function,
and TA cell proliferation and differentiation to maintain overall tis-
sue homeostasis are not well understood.
The Notch signaling pathway regulates several aspects of
intestinal epithelial cell homeostasis. Notch plays a key role in reg-
ulating epithelial cell fate, with pathway activation leading to
enterocyte differentiation (Fre et al., 2005; Jensen et al., 2000;
Stanger et al., 2005), while pathway inhibition promotes secretory
cell differentiation, including goblet, Paneth and endocrine cells
(Pellegrinet et al., 2011; Riccio et al., 2008; van Es et al., 2005;
VanDussen et al., 2012). Notch regulation of absorptive vs. secretory
cell fate occurs by transcriptional repression of the secretory lineage
transcription factor Atoh1. The expression of Atoh1 has been shown
to be both required (Shroyer et al., 2007; Yang et al., 2001) and
sufﬁcient (VanDussen and Samuelson, 2010) for concerted differ-
entiation of all secretory cell types. Conversely, enterocyte differ-
entiation results when Atoh1 expression is repressed (Shroyer et al.,
2007; Yang et al., 2001). Interestingly, the sole function of Notch to
regulate cell fate appears to be through regulation of Atoh1 and
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Atoh1 is genetically deleted (Kim and Shivdasani, 2011).
In addition to regulation of intestinal epithelial cell fate, Notch
signaling regulates epithelial cell proliferation, with pathway activa-
tion resulting in increased proliferation (Fre et al., 2005; Stanger et al.,
2005), while pathway inhibition leads to a marked reduction in
overall cell proliferation in the intestine (Pellegrinet et al., 2011; Riccio
et al., 2008; van Es et al., 2005; VanDussen et al., 2012). Moreover, we
and others have shown that Notch signaling is necessary for stem cell
proliferation and cell survival (Pellegrinet et al., 2011; VanDussen
et al., 2012). Pathway inhibition resulted in reduced expression of the
stem cell marker Olfm4, decreased numbers of LGR5þ stem cells and
reduced stem cell proliferation (VanDussen et al., 2012).
Expression of the 4 known Notch receptors (N1–4) and 5 ligands
(Dll1, 3, 4 and Jag1 and 2) is temporally and spatially controlled for
proper development and homeostasis of many tissues. N1 and N2
are both expressed in the adult intestinal epithelium (Fre et al., 2011;
Sander and Powell, 2004; Schroder and Gossler, 2002), and lineage
tracing studies suggest that both receptors are expressed in stem
cells (Fre et al., 2011), but individual roles for each receptor are not
well understood.
Previous studies investigating N1 and N2 functions utilizing
humanized inhibitory antibodies suggested a role for N1 in reg-
ulating intestinal homeostasis, as anti-N1 treatment showed a mild
secretory cell hyperplasia (Wu et al., 2010) and decreased intestinal
proliferation, and toxicity when paired with irradiation damage
(Tran et al., 2013). In contrast to these ﬁndings, genetic deletion
studies reported that individual loss of N1 or N2 in the intestinal
epithelium had no phenotype, and thus N1 and N2 were thought to
be fully functionally redundant in the gut (Riccio et al., 2008). Due to
the important therapeutic implications of intestinal Notch regula-
tion, it is important to reconcile these disparate ﬁndings.
In this study we used a genetic deletion model to deﬁnitively
show that N1 is the predominantly active Notch receptor in the
intestinal epithelium, as N1 receptor deletion led to secretory cell
hyperplasia and reduced stem cell number. Furthermore, we inves-
tigate the dynamic regulation of lost N1 signal and expand on the
understanding of how N1 and N2 function together to regulate pro-
liferation and differentiation in the intestine. Finally, we uncover an
unexpected sensitivity to loss of either N1 or N2 in irradiated intestine
with implications on therapeutic use of Notch receptor blockade.Materials and methods
Mice
Floxed-Notch1 (N1F/F) (Yang et al., 2004) (Jackson Lab, no.
007181), ﬂoxed-Notch2 (N2F/F) (McCright et al., 2006) (Jackson Lab,
no. 010525), ﬂoxed-Rbpjκ (RbpjF/F) (Tanigaki et al., 2002) (gift from
T. Honjo), Villin-CreERT2 (el Marjou et al., 2004) (gift from
S. Robine) and Lgr5-GFP-IRES-CreERT2 (Lgr5-GFP) (Barker et al.,
2007) (Jackson Lab, no. 008875) alleles were veriﬁed by PCR
genotyping with the primers listed in Supplementary Table 1. All
mouse strains were on a C57BL/6 strain background. Adult mice of
both sexes aged 2–4 months were analyzed for all experiments
except where indicated that juvenile mice aged 10 days were used.
Mice were housed in ventilated and automated watering cages
with a 12-h light cycle under speciﬁc pathogen-free conditions.
Protocols for mouse usage were approved by the University of
Michigan Committee on Use and Care of Animals.
Animal treatment protocols and tissue collection
To activate CreERT2-mediated recombination, mice were injected
intraperitoneally with 100 mg/kg tamoxifen (10 mg/ml in 5%ethanol and 95% corn oil, Sigma) or corn oil once per day for 5 days
and tissue was collected on day 6, unless otherwise noted. Corn oil-
treated control animals were found to have no background goblet
cell hyperplasia (data not shown). Juvenile mice were injected at 10
days of age via the same protocol except with 20 mg/ml tamoxifen
to achieve 100 mg/kg. To induce intestinal injury, animals were
exposed to one dose of 12 Gy whole body irradiation from a 137Cs
source. Animals were fasted overnight and injected intraperitoneally
with 25 mg/kg 5-ethynyl-2′-deoxyuridine (EdU) (Life Technologies)
2 h prior to tissue collection. Intestinal tissue was harvested and
ﬁxed in 4% paraformaldehyde in PBS (PFA) overnight before parafﬁn
processing as previously described (VanDussen et al., 2012). Tissue
prepared for frozen sections was ﬁxed in PFA for 1 h and placed in
30% sucrose overnight before embedding in OCT (Tissue-Tek).
Immunohistochemistry
Parafﬁn sections (5 μm) were stained with Periodic acid Schiff
and Alcian Blue (PAS/AB) (Newcomer Supply) to visualize mucin-
containing goblet cells. EdU-Click-it (Life Technologies) was used
to evaluate proliferating cell number. Immunostaining with rat
α-MMP7 (1:400, Vanderbilt Antibody and Protein Resource), rab-
bit α-MUC2 (1:200, Santa Cruz), rabbit α-CHGA (1:200, Abcam),
rat α-PROM1 (1:100, eBioscience) and rabbit α-Ki67 (1:200,
Thermo) was performed as described (Lopez-Diaz et al., 2006). For
AB/CHGA co-staining, tissues were stained with α-CHGA (1:100,
Abcam) and visualized with the DAB substrate kit (VectorLabs) per
manufacturer's instructions. Slides were then stained in AB for
30 min and counterstained in neutral red for 1 min. Transgenic
LGR5-GFP was directly imaged on frozen sections without anti-
body staining. Images were captured on a Nikon E800 microscope
with Olympus DP controller software.
In situ hybridization
Olfm4 cDNA plasmid (IMAGE clone 9055739) was linearized
and sense and antisense probes were made with DIG labeling kit
according to the manufacturer's instructions (Roche). Probes were
puriﬁed using the Min-Elute Gel Extraction kit (Qiagen). Slides
were deparafﬁnized, hydrated, and treated with 0.2 N HCl for
15 min at room temperature. Tissues were treated with Proteinase
K (30 μg/mL, Roche) for 30 min at 37 °C, post-ﬁxed in 4% PFA for
10 min, acetylated for 10 min in 13.4% triethanolamine, 0.2 M HCl
and 2.5% acetic anhydride, incubated with hybridization buffer
(50% deinonized formamide (Invitrogen), 10% dextran sulfate
(Millipore), 2% Denhardts (Sigma), 1 mg/mL yeast tRNA, 0.2 M
NaCl, 0.1 M Tris–HCl, pH 7.5, 0.1 M phosphate buffer, pH 6.8, 5 mM
EDTA, pH 8 in DEPC-treated H2O) for 1 h, followed by incubation
with Olfm4 probe diluted in hybridization buffer at 68 °C over-
night. Tissue sections were then washed, incubated in blocking
solution (20% heat-inactivated serum, 0.02 g/mL blocking reagent
(Roche)) in buffer (0.1 M Tris–HCl, pH 7.5, 0.15 M NaCl, 0.1% Tween
20 in sterile H2O) for 1 h, and anti-DIG antibody (1:2500, Roche)
overnight at 4 °C. Slides were washed and developed with NBT/
BCIP solution (1:100, Roche) in 0.1 M Tris–HCl, pH 9.5, 0.1 M NaCl,
0.05 M MgCl2, 0.5 mg/mL levamisole (Sigma) in sterile H2O.
Minimal signal was detected with Olfm4 sense probe control.
Quantitative morphometric analysis
All observers were blinded to slide identity for cell counting.
Goblet cell hyperplasia was measured as the number of crypts that
displayed increased goblet cells over total crypts per section. EdU
morphometrics was achieved by counting the total number of
epithelial EdUþ cells per well-oriented crypt and averaged per
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per crypt.Crypt isolation and ﬂow cytometry
Crypt isolation was performed on proximal jejunum (centimeters
9–15 as measured from the pylorus). Tissue was incubated in 15 mM
EDTA (Sigma) in DPBS (Gibco) at 4 °C for 35 min, vortexed for 2 min,
and ﬁltered through a 70 μm cell strainer (BD Bioscience). To obtain a
single cell suspension for ﬂow cytometry, puriﬁed crypts were
resuspended in TrypLE Express (Gibco), shaken at 37 °C for 10–12min,
and 0.1 mg/ml DNase I (Roche) and 10% fetal bovine serum (FBS) were
added. Cells were passed through a 40 μm cell strainer (BD
Bioscience), pelleted at 400 g, resuspended in 2% FBS, 0.05% sodium
azide (Sigma), 2 mM EDTA in DPBS and stained unﬁxed as follows.
All cells were blocked with rat α-mouse CD16/CD32 (1:100, BD
Bioscience), lymphocytes were excluded with CD45.2-PerCP-Cy5.5
(1:80, LifeTechnologies), epithelial cells were visualized with EpCAM-
APC (1:80, eBioscience), and dead cells were excluded by DAPI
(3.6 mM) incorporation. Cells were analyzed on a BD FACSCanto II and
analyzed with FlowJo software (Treestar). GFPþ cells were sequen-
tially gated for size, singlets, DAPI , CD45.2 , and EpCAMþ . For EdU
ﬂow analysis cells were stained with CD45.2-PerCP-Cy5.5 and
EpCAM-APC and then the EdU-Click-it Alexa-488 kit as per manu-
facturer's instructions. EdUþ cells were gated for size, singlets,
CD45.2 , and EpCAMþ .Gene expression analysis
RNA from full-thickness ileum or isolated jejunal crypts was
isolated by Trizol (Invitrogen) extraction followed by the RNeasy
Mini kit (Qiagen) with DNase I treatment as per manufacturer
instructions. cDNA was reverse transcribed with the iScript cDNA
synthesis kit (BioRad) using 1 μg of total RNA. Quantitative RT-PCR
was performed as described (Lopez-Diaz et al., 2006) with primer
sequences as described (VanDussen et al., 2012). Assays for each
sample were run in triplicate and normalized to glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) as an internal control.Gene deletion quantiﬁcation
For quantiﬁcation of N1 deletion, DNA was puriﬁed from isolated
crypts using the Easy-DNA kit (Invitrogen, cat# K1800-01). Quantita-
tive PCR was performed with 40 ng DNA using the following primers:
GCGCACGCTTTGGGTAGATA (forward) and ACACTTCCAGCGTCTTTGGG
(reverse) within the deleted sequence, and CTGGGACAACAGCA-
GCCTAA (forward) and GCCTTGCAGGCCTTAAGAGA (reverse) in a
reference sequence downstream of the N1 deletion site.Statistical analyses
Quantitative data are presented as mean7SEM, with all
experimental groups normalized to time-matched tamoxifen-trea-
ted controls. Comparisons between two groups were conducted
with unpaired two-tailed student t tests. Comparisons between
3 and more groups were analyzed by one-way ANOVA with Tukey's
or Dunett's post-tests as noted. Prism software (Graphpad) was used
for statistical analyses. Signiﬁcance is reported as *(Po0.05), **
(Po0.01), ***(Po0.001), and ****(Po0.0001).Results
Weight loss and secretory cell hyperplasia in N1-deleted intestine
To conditionally delete N1 in the intestinal epithelium, we
crossed the N1F/F mice (Yang et al., 2004) with transgenic mice
carrying a tamoxifen-regulated Villin-CreERT2 allele (el Marjou
et al., 2004). After tamoxifen treatment Villin-CreERT2; N1F/F
(N1Δ/Δ) mice transiently lost weight with a nadir (92% of initial
weight) occurring at day 8 (Fig. 1A). Although N1Δ/Δ animals
began to gain weight after day 8, they remained signiﬁcantly
lighter than controls until after day 35. We ﬁrst assessed secretory
cell populations in N1Δ/Δ intestines to determine if single receptor
loss was sufﬁcient to induce aberrant secretory cell differentiation.
PAS/AB staining for mucin-containing cells revealed a striking
increase in goblet cell abundance in the N1Δ/Δ terminal ileum
(Fig. 1) and all other regions of the intestine (Supplementary
Fig. 1). Interestingly, while increased goblet cells were observed in
over 80% of crypts on day 8, the number of aberrant crypts sig-
niﬁcantly declined over time. By day 60, only 6% of crypts still
maintained evidence of goblet cell hyperplasia (Fig. 1G), correlat-
ing with the normalization of N1Δ/Δ body weight (Fig. 1A). Of
note, epithelial N1 deletion was maintained at similar levels
throughout the time course (Fig. 1H) suggesting that the patchy
restoration of normal goblet cell differentiation is through a
N1-independent compensatory mechanism.
Interestingly, we observed a similar recovery pattern with com-
plete genetic blockade of Notch signaling by crossing Villin-CreERT2
with RbpjF/F mice, and treating with tamoxifen (RbpjΔ/Δ). Adminis-
tration of two doses of tamoxifen in this model results in complete
goblet cell hyperplasia by day 7 followed by patchy normalization
over time (Supplementary Fig. 2), indicating that this recovery
response is not unique to N1 loss.
To investigate if other secretory cell types were increased in
N1Δ/Δ mice, we stained for the Paneth cell marker MMP7 and
endocrine cell marker CHGA, and observed increased numbers of
both populations (Supplementary Fig.1I and M). Further analysis
revealed co-localization of goblet and Paneth cell markers in
N1Δ/Δ crypts (Supplementary Fig. 3). This ﬁnding is consistent
with previous observations of global Notch inhibition in DBZ-
treated mice (VanDussen et al., 2012). Although these co-stained
cells do not follow typical mature goblet or Paneth cell differ-
entiation programs, they do not co-express endocrine markers nor
appear to be actively cycling (Supplementary Fig. 4).
Analysis of mRNA for secretory cell transcription factors and
differentiated cell markers paralleled the observed secretory cell
hyperplasia in the N1Δ/Δ intestine as well as the time-dependent
phenotype regression (Fig. 2). Markers of all secretory cell lineages
were signiﬁcantly increased by day 8. Expression of the transcription
factor Atoh1, which drives the differentiation of all secretory cell
types (Shroyer et al., 2007; Yang et al., 2001), the goblet cell marker
Muc2, and endocrine markers Neurog3 and ChgA normalized by day
60. In contrast, Spdef, which is important for the terminal differ-
entiation of goblet and Paneth cells (Gregorieff et al., 2009; Noah
et al., 2010) as well as Mmp7 remained ampliﬁed 2.4- and 1.7-fold
respectively on day 60. Indeed, the MUC2/MMP7 co-stained cells
were still observed in a patchy distribution in both the small
intestine and colon 60 days after N1 deletion (Supplementary Fig. 3),
consistent with the continued elevation of these markers.
Notch ligand expression in secretory cells
DLL1 and DLL4 have been shown to be the primary ligands
regulating the intestinal stem and progenitor compartment (Pel-
legrinet et al., 2011). Therefore, we analyzed transcript levels of
Dll1 and Dll4 in N1Δ/Δ intestine. Expression of both ligands was
Fig. 1. Intestinal epithelial N1 deletion leads to transient weight loss and goblet cell hyperplasia. (A) Weight curve of Villinþ /þ; N1F/F (Control) and Villin-CreERT2; N1F/F
(N1Δ/Δ) animals treated for 5 days with 100 mg/kg tamoxifen (TAM). Bar represents duration of TAM treatment. Weights at each time point are compared with Student’s t
tests. (B–F) PAS/AB stained goblet cells in control (B) or N1Δ/Δ ileum (C–F) at the time points indicated. (G) Quantiﬁcation of ileal goblet cell hyperplasia presented as percent
total crypts. Data were analyzed by ordinary one-way ANOVA with Tukey's multiple comparisons test. N¼3–6 animals/group. (H) Quantiﬁcation of N1 genomic DNA in
control and N1Δ/Δ animals. Values were normalized to a reference sequence within N1, downstream of the deletion area, and shown as fold-change compared to control by
Student’s t-test. N¼3–6 animals/group. *(Po0.05), **(Po0.01), ***(Po0.001), and ****(Po0.0001) Scale bar¼100 μm.
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Importantly, the overexpression of Dll1 and Dll4 in N1Δ/Δ animals
subsided over time, similar to the secretory cell markers discussed
above, suggesting increased ligand presentation is limited to the
secretory cell expansion period.
N2-deleted intestine shows no change in differentiation
We next analyzed N2 deletion to determine if genetic deletion of
this receptor led to any epithelial cell changes. To achieve speciﬁc
intestinal epithelial deletion Villin-CreERT2 was crossed to N2F/F mice
(McCright et al., 2006). In contrast to N1Δ/Δ, tamoxifen-treated
Villin-CreERT2; N2F/F (N2Δ/Δ) animals did not lose weight post-
treatment (data not shown), and no goblet cell changes were evi-
dent in N2Δ/Δ intestine (Fig. 3). Furthermore, no transcriptional
changes were observed in genes encoding secretory cell transcrip-
tion factors, differentiated cell markers, or Notch ligands (Fig. 3).N1 and N2 function additively for secretory cell differentiation
While N1Δ/Δ animals displayed a distinct secretory cell hyperpla-
sia, the severity of the phenotype was less profound than published
reports of double Notch receptor gene deletion (N1Δ/Δ; N2Δ/Δ) (Riccio
et al., 2008) as well as pharmacologic Notch inhibition (van Es et al.,
2005; VanDussen et al., 2012). Thus, we analyzed compound deletions
of N1 and N2 to assess dosage effects of Notch receptors on secretory
cell fate. Goblet cells were visualized by PAS/AB staining in N1 het-
erozygotes (N1Δ/þ), compound partial deletions (N1Δ/þ; N2Δ/Δ and
N1Δ/Δ; N2Δ/þ) and double knockout (N1Δ/Δ; N2Δ/Δ) animals. Het-
erozygote N1Δ/þ animals displayed no increase in goblet cells (Fig. 4),
indicating that a loss of both N1 alleles is required for the secretory
cell effect. Compound partial deletions N1Δ/þ; N2Δ/Δ and N1Δ/Δ;
N2Δ/þ each displayed a more severe goblet cell hyperplasia compared
to N1Δ/Δ, albeit less severe than the total knockout N1Δ/Δ; N2Δ/Δ.
These ﬁndings were paralleled by analysis of mRNA transcripts for
Fig. 2. Secretory cell markers and Notch ligands are transiently upregulated in N1Δ/Δ intestine. Quantitative RT-PCR analysis of secretory cell transcription factors (A–C),
differentiated secretory cell markers (D–F) and Notch ligands (G,H) in tamoxifen-treated Villinþ /þ; N1F/F (Control) and N1Δ/Δ animals at the time points indicated. RNA was
isolated from full-thickness ileum. All values were normalized to Gapdh expression level and reported as fold change compared to control. Data were compared with
ordinary one-way ANOVA with Dunnett's post-test. N¼3–6 animals/group.
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additively to regulate epithelial cell differentiation.
N1 and N2 function redundantly for proliferation
Another hallmark of intestinal Notch inhibition is decreased
epithelial proliferation (Pellegrinet et al., 2011; Riccio et al., 2008;
van Es et al., 2005; VanDussen et al., 2012). Despite the robust
secretory cell phenotype, no loss of proliferation was observed in
N1Δ/Δ, as measured by ﬂow cytometry for crypt epithelial EdUþ
cells (Fig. 5A). To determine the contribution of each receptor to
regulation of epithelial proliferation, EdUþ cells were assessed in all
Notch receptor deletion combinations (Fig. 5B–H). Interestingly, only
double Notch receptor deletion resulted in a signiﬁcant reduction in
proliferation, suggesting that N1 and N2 function fully redundantly
for this process, and that markedly reduced levels of Notch signaling
can sustain the bulk of intestinal epithelial proliferation.
N1 is the primary receptor regulating stem cells
We have previously shown that Notch signaling is crucial for
maintenance of the LGR5þ crypt base columnar (CBC) stem cell
population (VanDussen et al., 2012), and thus questioned whether
the secretory cell changes in the N1Δ/Δ intestine were coupled
with altered stem cell homeostasis. Olfm4 is a CBC marker (van der
Flier et al., 2009) as well as a direct Notch target gene (VanDussenet al., 2012), which can be used as a faithful read-out of Notch
suppression in active stem cells. In situ hybridization for Olfm4
showed profound loss of expression in N1Δ/Δ intestine 6 days after
tamoxifen induction (Fig. 6A). Expression of classic Notch target
genes Hes1 and Myc were also signiﬁcantly decreased in N1Δ/Δ
intestine (Supplementary Fig. 5). Interestingly, while Hes1 andMyc
expressions fully recovered to baseline by Day 60, Olfm4 expres-
sion only partially recovered, with maintenance of patchy crypts
negative for Olfm4 expression at 60 days (Supplementary Fig. 5).
Consistent with the absence of other epithelial changes, N2Δ/Δ
animals displayed no change in Olfm4 expression by in situ
hybridization or mRNA expression analysis (Fig. 6A and B). All
other combinations of receptor gene deletion, however, showed
signiﬁcantly reduced Olfm4 transcript levels (Fig. 6B). Interestingly,
the N1Δ/þ animals showed reduced Olfm4 expression that was not
signiﬁcantly different from N1Δ/þ; N2 Δ/Δ intestine, suggesting
that the additional loss of both N2 alleles has very little effect on
Olfm4. Likewise, while N1Δ/Δ animals expressed signiﬁcantly less
Olfm4 than N1Δ/þ heterozygotes, expression was not further
reduced in N1Δ/Δ; N2Δ/þ animals. These results suggest that N1 is
the primary receptor required for Notch target gene activation in
the active intestinal stem cell population.
To more speciﬁcally determine the N1-dependence of CBC stem
cells, we crossed the Villin-CreERT2; N1F/F mice to Lgr5-GFP mice (Bar-
ker et al., 2007) to allow visualization of LGR5þ stem cells by GFP
expression. We employed ﬂow cytometry on single cells isolated from
Fig. 3. N2 deletion in the intestinal epithelium does not result in secretory cell changes. Villinþ /þ; N2F/F (Control) or Villin-CreERT2; N2F/F (N2Δ/Δ) animals were treated with
100 mg/kg TAM daily for 5 days and harvested on day 6. (A,B) PAS/AB staining for goblet cells in control (A) and N2Δ/Δ (B) ileum. No marked increases in goblet cells were
observed in the N2Δ/Δ animals. (C) qRT-PCR analysis of secretory transcription factors, differentiated secretory cell markers, and Notch ligands. Data are presented as mRNA
fold-change and comparisons were made with Student's t tests compared to control, which was normalized to 1 (dashed line). No signiﬁcant changes were observed for any
marker gene. (Neurog3, P¼0.14; Mmp7, P¼0.18). N¼3–6 animals/group. Scale bar ¼100 μm.
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on day 6 after the start of tamoxifen treatment. As there is a gradient
of GFP expression in LGR5-GFP crypts (Sato et al., 2009) (Fig. 6C), we
focused on GFPHI cells to explicitly measure changes in LGR5þ CBCs
(Fig. 6D–F). In controls, 30% of total GFPþ cells were GFPHI, while
N1Δ/Δ mice retained only 14% GFPHI cells, a 53% reduction from
baseline. Consistent with the Olfm4 results, Lgr5 mRNA abundance
only partially recovered after 60 days (Supplementary Fig. 5).
Both N1 and N2 are required for post-irradiation recovery
Finally, we investigated the role of Notch receptors on intestinal
repair. To assess this, we treated N1Δ/Δ and N2Δ/Δ animals and their
respective controls with tamoxifen and then administered 12 Gy of
whole body irradiation. Both groups quickly lost weight compared to
controls, and mice were euthanized 3 days post-irradiation when
the N1Δ/Δ group was moribund (Fig. 7A and B). In contrast, although
the control groups also lost weight, a parallel experiment demon-
strated that they survived at least 8 days post-irradiation and
regained stem cell marker expression before succumbing to bone
marrow insufﬁciency (Supplementary Fig. 6). PAS/AB staining
showed increased goblet cells in the N1Δ/Δ group (Fig. 7E), con-
sistent with the phenotype observed in non-irradiated animals at
this time point (Fig. 1). Irradiated N2Δ/Δ tissues did not have
increased goblet cells, but displayed abnormal secretory cell dis-
tribution reﬂective of altered epithelial architecture (Fig. 7G). Nor-
mal intestine experiences a proliferative surge post-irradiation aspart of the recovery response (Paulus et al., 1992; Van Landeghem
et al., 2012; Yan et al., 2012). To determine if N1 and N2 were
essential for this process, we analyzed EdU incorporation in all
groups (Fig. 7H–N). While irradiated control animals displayed a
visible increase in the number of EdUþ cells compared to uni-
rradiated controls, the N1Δ/Δ and N2Δ/Δ tissues were almost com-
pletely devoid of proliferative cells, suggesting that while neither
receptor is critical for proliferation during normal homeostasis, they
are both required for post-injury proliferation.Discussion
We present here an expanded understanding of Notch receptor
function in the intestinal epithelium. During normal homeostasis
N1 is the primary receptor responsible for differentiation and stem
cell maintenance. Epithelial deletion of N1 results in a transient
secretory cell hyperplasia, with overproduction of all secretory cell
types. Additionally, our study used the Lgr5-GFP mouse model in
combination with N1 deletion to show that loss of N1 acutely
disrupts CBC stem cell homeostasis. We report new evidence that
expression of either N1 or N2 is sufﬁcient for normal proliferation
during homeostasis, but that expression of both N1 and N2 is
required for crypt regeneration in the post-irradiation setting.
Previous studies suggested that N1 is important for stem cells
since its expression was found to be highest in CBCs compared
to other crypt cells (Munoz et al., 2012; Sato et al., 2010).
Fig. 4. N1 and N2 function additively to regulate epithelial differentiation. Control animals were pooled Villinþ /þ; N1F/þ; N2F/F and Villinþ /þ; N1F/þ . All control and
experimental groups were injected with 100 mg/kg TAM daily for 5 days and harvested on day 6. (A–F) PAS/AB staining for goblet cells in control (A), N1Δ/þ (B) N1Δ/Δ (C),
N1Δ/þ; N2Δ/Δ (D) N1Δ/Δ; N2Δ/þ (E) N1Δ/Δ; N2Δ/Δ (F) ileum. (G) Quantitative RT-PCR analysis for secretory cell markers in all groups. Data are compared to control with
ordinary one-way ANOVA and Dunnett's post-test. N¼3–5 animals/group. Scale bar¼100 μm.
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undergoing active N1 cell-surface cleavage (Vooijs et al., 2007)
have been shown to lineage trace into entire crypts, the gold-
standard for deﬁning stem cells in vivo. To our knowledge, only
one other study has investigated the function of N1 in intestinal
stem cells. Vooijs et al. (2007) engineered blastocyst chimeras with
wild-type and LacZ-expressing N1 deﬁcient cells and analyzed the
resulting adult intestines. Rare LacZ expression was observed in
adult chimeras, suggesting that stem cells lacking N1 were capable
of persisting over time. They concluded that while N1 was active
in stem cells, it was not required for stem cell maintenance. Ourresults are in agreement with this study as we observed that
N1-deleted stem cells can persist for several weeks. However, our
observation that stem cell marker Olfm4 and Lgr5 expression
remain decreased after two months of N1 deletion while other
Notch target genes fully recover suggests that stem cell number is
sensitive to N1 expression.
Additionally, while our study bolsters the secretory cell ﬁndings
reported with N1-inhibitory antibody treatment (Wu et al., 2010)
and chimeric N1-deleted intestine (Vooijs et al., 2007), another
study using the same model system we have employed in our
experiments found that Villin-CreERT2; N1Δ/Δ mice had no
Fig. 5. N1 and N2 are fully redundant for intestinal epithelial proliferation. Animals were treated with EdUþ 2 h before tissue collection. (A) EdUþ cells in dissociated
epithelial cells from tamoxifen-treated Villinþ /þ; N1F/F (Control) and N1Δ/Δ jejunum were analyzed by ﬂow cytometry. Data are presented as percent of EpCAMþ cells gated
for size, singlets and CD45-. No change was observed in N1Δ/Δ (day 6) compared to control. (B–G) Representative images of ileal proliferation as visualized by EdU uptake in
all genotypes as indicated. (H) Morphometric quantiﬁcation of proliferative cells. Data are presented as average EdUþ cells/crypt. Control group is pooled day 6 and day
8 tamoxifen-treated Villinþ /þ; N1F/F controls, which were shown to be the same. Quantitative data are compared with ordinary one-way ANOVA and Dunnett's post-test.
N¼3–5 animals/group. Scale bar ¼100 μm.
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results. Importantly, the Riccio et al. study was conducted in juvenile
rather than adult mice. To determine if there is an age-dependent
window during which N1 plays a more minimal role in secretory celldifferentiation we analyzed Villin-CreERT2; N1F/F mice injected with
tamoxifen starting at 10 days of age. In concordance with our ﬁnd-
ings in adults, we observed increased goblet cell production in
juvenile mice (Supplementary Fig. 7) suggesting that N1 becomes
Fig. 6. LGR5þ stem cells are depleted with N1 deletion. (A) In situ hybridization for Olfm4 in N1Δ/Δ and N2Δ/Δ jejunum. Controls are tamoxifen-treated Villinþ /þ; N1F/F and
Villinþ /þ; N2F/F respectively. (B) Quantitative qRT-PCR for Olfm4 in all Villin-CreERT2 Notch receptor deletion groups. Control group is pooled tamoxifen-treated Villinþ /þ;
N1F/þ; N2F/F and Villinþ /þ; N1F/þ animals. Comparisons are made by ordinary one-way ANOVA and Tukey post-test. (C) High powered view of an Lgr5-GFP (green) mouse
crypt co-stained for Prominin-1 (PROM1, red) and DAPI (blue). GFP shows a gradient of expression, with highest intensity in CBCs at the crypt base. (D–F) Flow cytometric
analysis of Lgr5-GFP cells. Control (Lgr5-GFP; N1þ /þ) and Villin-CreERT2; Lgr5-GFP; N1F/F animals were injected with 100 mg/kg TAM daily for 5 days and harvested on day 6.
(D,E) Scatter plots of GFP expression in single, live, CD45.2 EpCAMþ crypt epithelial cells in control (D) and Lgr5-GFP; N1Δ/Δ (E) animals. Gates indicate GFPHI populations
and GFPTOTAL populations. (F) Quantiﬁcation of GFPHI cells. Data are presented as percentage of GFPTOTAL cells. N¼3–4 animals/group.
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period. Thus, at this time, while we cannot explain why the Riccio
et al. study did not observe a phenotype in N1Δ/Δ intestine, we
presume that differences in tamoxifen treatment concentrations,
chase times post-treatment, as well as variation in recombination
frequencies may have contributed to the different results.
Our study is the ﬁrst to show dynamic regulation of secretory cell
fate in Notch deletion models. Interestingly, although over-
expression of goblet and endocrine cell markers resolved by
2 months after N1 deletion, the presence of Paneth/goblet co-
stained cells persisted in N1Δ/Δ animals. While it is agreed that
Paneth cells are much longer lived than other differentiated intest-
inal epithelial cells, the exact length of the Paneth cell lifespan is
disputed, with estimates ranging from 18 to 60 days (Cheng et al.,
1969; Ireland et al., 2005). The continued presence of co-stained
goblet/Paneth cells after 60 days suggests that these aberrantco-stained cells have a lifespan similar to mature Paneth cells and
that once cells are speciﬁed as expressing both Paneth and goblet
cell markers, they do so for the duration of their lifespan.
This study uniquely offers a detailed analysis of compound
Notch receptor deletions in the intestine. By serially deleting 1 to
4 alleles of the N1 and N2 genes, we have discovered differences in
the regulation of differentiation, proliferation, and stem cell
maintenance. Although N1Δ/Δ results in secretory cell hyperplasia
while N2Δ/Δ does not, combined deletions result in a more severe
secretory cell phenotype. This ﬁnding suggests that these recep-
tors function additively for secretory cell fate. In contrast, only
double receptor deletion (N1Δ/Δ; N2Δ/Δ) showed a signiﬁcant loss
of epithelial proliferation, indicative of full redundancy of N1 and
N2 function for proliferation and suggestive that N2 signaling in
the absence of N1 is capable of maintaining proper proliferation
but unable to maintain normal differentiation. Furthermore, this
Fig. 7. N1 and N2 are required for post-irradiation intestinal recovery. (A,B) N1Δ/Δ and N2 Δ/Δ animals and their respective controls Villinþ /þ; N1F/F (N1þ /þ) and Villinþ /þ;
N2F/F (N2þ /þ) were treated with 100 mg/kg TAM daily for 5 days, administered 12 Gy of whole body irradiation on day 6 and harvested on day 9 when the N1Δ/Δ group had
lost more than 20% body weight and was moribund (cross). (C–G) PAS/AB staining for goblet cells in ileum of the above groups. (H–L) Proliferation was assessed in ileum by
EdU incorporation. (C,H) An unirradiated N1þ /þ control group treated with tamoxifen for 5 days and harvested on day 9 is included for comparison. (M,N) Quantiﬁcation of
EdU uptake in irradiated animals. N¼3–4 animals/group. Scale bar¼100 μm.
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Notch signaling tone. The separation of these two phenotypes may
allow pharmacological opportunities to regulate differentiation
while sparing proliferation.
Finally, we discovered that deletion of either N1 or N2 renders the
intestine highly susceptible to irradiation injury, resulting in altered
epithelial architecture and almost complete loss of proliferation. This
is consistent with the irradiation susceptibility of N1-inhibitory anti-
body-treated animals (Tran et al., 2013), and extends this ﬁnding to an
epithelial-speciﬁc effect of N1 deletion. Importantly, this is the ﬁrst
report of N2 sensitivity in the post-irradiation setting and the ﬁrst
intestinal phenotype to be described in N2Δ/Δmice. As deletion of N2
has no apparent affect on the active stem cell population, these
ﬁndings may suggest a higher level of required Notch activity in
reserve stem cell populations. Indeed Qu et al. (2014) found that Notch
inhibition resulted in fewer Dclk1þ cells after irradiation, a putative
reserve stem cell population. Our ﬁndings are signiﬁcant for the
potential use of Notch as a pharmacologic target for cancer treatment.
Because most successful therapeutic schemes are combined withinjury-inducing chemotherapies or radiation, concomitant treatment
with N1 or N2 inhibition could be deleterious.
In conclusion, the N1 receptor plays a primary role in regulat-
ing intestinal epithelial cell fate, stem cell maintenance and repair.
N2 has a minimal role during homeostasis but is required for crypt
regeneration in the post-injury setting. Therapeutic inhibition of
these receptors should be approached with caution due to the
important role they play in homeostasis and repair.Acknowledgments
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